Hawaii bills · 2026 Regular Session
Hawaii SB 2933
RELATING TO HEALTH CARE COSTS.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
Summary
Official abstract published by the Hawaii legislature· description
Establishes the Prescription Drug Affordability Board within the Department of Health to conduct affordability reviews on high-cost prescription drugs and establish upper payment limits under certain circumstances. Establishes out-of-pocket maximums for prescribed insulin, asthma inhalers, and epinephrine auto-injectors. Prohibits copayment adjustment programs. Requires health insurers, mutual benefit societies, and health maintenance organizations to comply with certain affordability measures. Requires annual reports to the Legislature. Requires adoption of rules by the Affordability Board and Insurance Commissioner. Appropriates funds.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 23, 2026 · Senate
Introduced. - Jan 26, 2026 · Senate
Passed First Reading. - Jan 30, 2026 · Senate
Referred to HHS/CPN, WAM/JDC. - Feb 13, 2026 · Senate
The committee(s) on HHS/CPN has scheduled a public hearing on 02-17-26 9:45AM; Conference Room 229 & Videoconference. - Feb 17, 2026 · Senate
The committee(s) on HHS/CPN deferred the measure until 02-18-26 10:06AM; Conference Room 229 & Videoconference. - Feb 18, 2026 · Senate
The committee on HHS deferred the measure. - Feb 18, 2026 · Senate
The committee on CPN deferred the measure.